Literature DB >> 9747147

Calciphylaxis: a syndrome of skin necrosis and acral gangrene in chronic renal failure.

J Hafner1, G Keusch, C Wahl, G Burg.   

Abstract

BACKGROUND: Calciphylaxis is a rare condition of rapidly extending ischemic skin necrosis or acral gangrene of fingers, toes or penis in patients with chronic renal failure. It may be accompanied by extensive metastatic calcification of soft tissues. Histology of infarcted tissues shows prominent medial calcification and intimal hyperplasia of subcutaneous arteries and/or digital arteries, respectively. The pathogenesis of calciphylaxis is only poorly understood. Most patients have hyperparathyroidism and an elevated calcium-phosphate-product, which is thought to be a major pathogenetic factor of calciphylaxis. PATIENTS AND METHODS: All published cases of calciphylaxis including nine of own (155 patients in total) from 1936 through 1996 were reviewed and subjected to statistical meta-analysis (Fisher's exact test).
RESULTS: Proximal locations of necrosis (thighs, buttocks, trunk) carried an unfavourable prognosis (63% mortality) compared to distal locations (calves, forearms, fingers, toes, penis) with 23% mortality (p < 0.0001). Parathyroidectomy was associated with a favourable outcome (p < 0.004). Diabetics with chronic renal failure had acral gangrene in 61% compared to 34% of the non-diabetic calciphylaxis-patients (p < 0.007).
CONCLUSIONS: The present analysis of all published cases of calciphylaxis is limited by patient selection and publication bias. The unfavourable prognosis of patients with proximal necrosis is impressive and might justify an early and aggressive treatment in such cases. However, the general benefit of parathyroidectomy remains debatable. Hyperparathyroidism should be managed primarily by conservative means. Parathyroidectomy should be reserved for patients with very high parathyroid hormone level and calcium-phosphate-product or with a rapidly progressive disease.

Entities:  

Mesh:

Year:  1998        PMID: 9747147

Source DB:  PubMed          Journal:  Vasa        ISSN: 0301-1526            Impact factor:   1.961


  9 in total

1.  [Calciphylaxis. A less well-known, clinically relevant disease].

Authors:  J D Strehl; V Brandenburg; C Forster; C Willam; A Hartmann; K Amann
Journal:  Pathologe       Date:  2011-05       Impact factor: 1.011

Review 2.  The surgical management of renal hyperparathyroidism.

Authors:  Catherine Madorin; Randall P Owen; William D Fraser; Phillip K Pellitteri; Brian Radbill; Alessandra Rinaldo; Raja R Seethala; Ashok R Shaha; Carl E Silver; Matthew Y Suh; Barrie Weinstein; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-20       Impact factor: 2.503

Review 3.  Calciphylaxis.

Authors:  R V Mathur; J R Shortland; A M el-Nahas
Journal:  Postgrad Med J       Date:  2001-09       Impact factor: 2.401

4.  Suspected systemic calcinosis and calciphylaxis in 5 horses.

Authors:  Jean-Yin Tan; Stephanie J Valberg; Manu M Sebastian; Gordon D Davis; Jenny R Kelly; Lutz S Goehring; Malte M Harland; K Leann Kuebelbeck; Bryan M Waldridge; Joseph C Newton; Johanna M Reimer
Journal:  Can Vet J       Date:  2010-09       Impact factor: 1.008

5.  Calcific uremic arteriolopathy: an underrecognized entity.

Authors:  Victoria Ann Kumar
Journal:  Perm J       Date:  2011

6.  Treatment of severe metastatic calcification and calciphylaxis in dialysis patients.

Authors:  Saurabh K Goel; Keith Bellovich; Peter A McCullough
Journal:  Int J Nephrol       Date:  2011-02-24

7.  Calciphylaxis associated with chronic kidney disease and low bone turnover: management with recombinant human PTH-(1-34).

Authors:  Grahame Elder; Karthic S Kumar
Journal:  NDT Plus       Date:  2008-02-14

8.  Calciphylaxis in a 33-year-old man with end-stage renal disease.

Authors:  Khalid M Al-Ghamdi
Journal:  Ann Saudi Med       Date:  2005 Sep-Oct       Impact factor: 1.526

9.  Case Report: Penile necrosis associated to paraphimosis with calciphylaxis due to terminal chronic kidney disease.

Authors:  J Antonio Grandez-Urbina; Elizabeth Corrales-Acosta; J Eduardo Tejeda-Mariaca; Rafael Pichardo-Rodriguez; Herney Garcia-Perdomo
Journal:  F1000Res       Date:  2019-07-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.